Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Janssen to start phase III trial of daratumumab in multiple myeloma in Q4 2014 Genmab partner Janssen Biotech (Janssen) is planning to start a new phase III trial of daratumumab for the treatment of patients with multiple myeloma during the fourth quarter of 2014. Contract Research & Services > Clinical Trials > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Novartis reports positive results for LCZ696 drug to treat chronic heart disease
By PBR Staff Writer
Swiss drugmaker Novartis has revealed positive results from its Phase III PARADIGM-HF trial of its LCZ696 drug in patients with heart failure with reduced ejection fraction (HF-REF).
Contract Research & Services > Clinical Trials > News
Immunotech completes Phase I and Phase II field trials of patented treatment of HIV/AIDS and hepatitis C viruses
Immunotech Laboratories has announced that the Phase I and Phase II field trials in Bulgaria of the company’s HIV/AIDS and Hepatitis C virus treatment (“ITV-1 Treatment”) have been successfully completed.
Contract Research & Services > Clinical Trials > News

Contract Research

Biothera gets NIH funding to further develop fungal vaccine
By PBR Staff Writer
US-based biotechnology firm Biothera has received a small business innovation research grant from the National Institutes of Health (NIH) to continue development of a fungal vaccine that may protect against infection from many different fungal species.
Contract Research & Services > Contract Research > News
Synexus acquires research centre in South Africa
Synexus has expanded its global presence with the acquisition of a specialist clinical trial site close to Cape Town’s international airport.
Contract Research & Services > Contract Research > News

Contract Services

Innovus and DanaLife ink marketing, distribution deal for Zestra in alternative markets
By PBR Staff Writer
Innovus Pharmaceuticals has signed an exclusive marketing and distribution agreement to grant Denmark-based DanaLife an 18-month worldwide distribution right (excluding Canada), to market and sell its topical consumer care product Zestra.
Contract Research & Services > Contract Services > News
Concert Pharma secures $2m payment for new drug product AVP-786
By PBR Staff Writer
Concert Pharmaceuticals has received a $2m milestone as part of a development and license agreement with Avanir Pharmaceuticals for the clinical progression of AVP-786 in patients with major depressive disorder (MDD).
Contract Research & Services > Contract Services > News